[go: up one dir, main page]

MX2010010209A - 4-hidroxipirimidina-5-carboxamidas sustituidas. - Google Patents

4-hidroxipirimidina-5-carboxamidas sustituidas.

Info

Publication number
MX2010010209A
MX2010010209A MX2010010209A MX2010010209A MX2010010209A MX 2010010209 A MX2010010209 A MX 2010010209A MX 2010010209 A MX2010010209 A MX 2010010209A MX 2010010209 A MX2010010209 A MX 2010010209A MX 2010010209 A MX2010010209 A MX 2010010209A
Authority
MX
Mexico
Prior art keywords
hydroxypyrimidine
substituted
carboxamides
conditions
relates
Prior art date
Application number
MX2010010209A
Other languages
English (en)
Inventor
Matthew J Clements
John S Debenham
Jeffrey J Hale
Christina B Madsen-Duggan
Thomas F Walsh
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MX2010010209A publication Critical patent/MX2010010209A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a 4-hidroxipirimidina-5-carboxami das sustituidas útiles como inhibidores de prolilhidroxilasas de HIF para tratar anemia y afecciones similares.
MX2010010209A 2008-03-18 2009-03-09 4-hidroxipirimidina-5-carboxamidas sustituidas. MX2010010209A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6986408P 2008-03-18 2008-03-18
US19291808P 2008-09-23 2008-09-23
PCT/US2009/036501 WO2009117269A1 (en) 2008-03-18 2009-03-09 Substituted 4-hydroxypyrimidine-5-carboxamides

Publications (1)

Publication Number Publication Date
MX2010010209A true MX2010010209A (es) 2010-10-05

Family

ID=40627533

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010010209A MX2010010209A (es) 2008-03-18 2009-03-09 4-hidroxipirimidina-5-carboxamidas sustituidas.

Country Status (13)

Country Link
US (1) US8278304B2 (es)
EP (1) EP2257539B1 (es)
JP (1) JP5557832B2 (es)
CN (1) CN102036981B (es)
AR (1) AR070925A1 (es)
AU (1) AU2009225869B2 (es)
CA (1) CA2718528C (es)
CL (1) CL2009000639A1 (es)
ES (1) ES2524883T3 (es)
MX (1) MX2010010209A (es)
PE (1) PE20091627A1 (es)
TW (1) TW200944511A (es)
WO (1) WO2009117269A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20141038T2 (hr) 2008-04-28 2015-07-03 Janssen Pharmaceutica N.V. Benzoimidazoli kao inhibitori prolil hidroksilaze
EP2326625A1 (en) * 2008-07-18 2011-06-01 Takeda Pharmaceutical Company Limited Benzazepine derivatives and their use as hstamine h3 antagonists
CN102388037B (zh) 2009-02-10 2014-12-03 詹森药业有限公司 作为脯氨酰羟化酶抑制剂的喹唑啉酮
CN102802629A (zh) * 2009-06-30 2012-11-28 默沙东公司 取代的4-羟基嘧啶-5-甲酰胺
JP2012532128A (ja) 2009-06-30 2012-12-13 メルク・シャープ・エンド・ドーム・コーポレイション 置換４−ヒドロキシピリミジン−５−カルボキサミド
AR077999A1 (es) * 2009-09-02 2011-10-05 Vifor Int Ag Antagonistas de pirimidin y triazin-hepcidina
PT2488486T (pt) 2009-10-13 2019-11-05 Ligand Pharm Inc Compostos de moléculas pequenas de mimética de fator de crescimento hematopoiético e utilizações dos mesmos
CA2776480A1 (en) * 2009-10-20 2011-04-28 Pfizer Inc. Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
WO2011049127A1 (ja) * 2009-10-21 2011-04-28 第一三共株式会社 炭化水素環基を有する５－ヒドロキシピリミジン－４－カルボキサミド誘導体
TW201141485A (en) * 2010-01-08 2011-12-01 Takeda Pharmaceutical Compounds and their use
US9006433B2 (en) 2010-04-21 2015-04-14 Merck Sharp & Dohme Corp. Substituted pyrimidines
UY33469A (es) * 2010-06-29 2012-01-31 Irm Llc Y Novartis Ag Composiciones y metodos para modular la via de señalizacion de wnt
AU2011289230B2 (en) 2010-08-13 2014-09-04 Janssen Pharmaceutica Nv 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
US9302991B2 (en) 2010-10-18 2016-04-05 Raqualia Pharma Inc. Arylamide derivatives as TTX-S blockers
GB201102659D0 (en) 2011-02-15 2011-03-30 Isis Innovation Assay
WO2012177896A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
EP2723717A2 (en) 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
GB201113101D0 (en) 2011-07-28 2011-09-14 Isis Innovation Assay
CA2845933C (en) 2011-09-06 2020-06-09 New York Blood Center, Inc. Hiv inhibitors
WO2013040789A1 (en) * 2011-09-23 2013-03-28 Merck Sharp & Dohme Corp. Substituted pyrimidines
WO2013043624A1 (en) 2011-09-23 2013-03-28 Merck Sharp & Dohme Corp. Substituted pyrimidines
WO2013040790A1 (en) * 2011-09-23 2013-03-28 Merck Sharp & Dohme Corp. Substituted pyrimidines
WO2013043621A1 (en) 2011-09-23 2013-03-28 Merck Sharp & Dohme Corp. Substituted pyrimidines
MX368157B (es) 2011-10-25 2019-09-20 Janssen Pharmaceutica Nv Formulaciones de sal de meglumina del acido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxilico.
ES2649905T3 (es) 2012-03-30 2018-01-16 Daiichi Sankyo Company, Limited Derivado de ácido (2-heteroarilamino)succínico
CN103450194B (zh) * 2012-06-05 2015-07-08 首都医科大学 四氢-β-咔啉-3-甲酰脂肪链胺、其制备、纳米结构、免疫抑制作用及应用
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
PE20151860A1 (es) * 2013-03-29 2015-12-16 Takeda Pharmaceutical Derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida y su uso como inhidores de la phd
KR20160100329A (ko) 2013-12-20 2016-08-23 3-브이 바이오사이언시스, 인코포레이티드 지질 합성의 헤테로사이클릭 조절물질 및 이들의 조합물
JP2017114765A (ja) * 2014-04-25 2017-06-29 大正製薬株式会社 トリアゾリルで置換されたヘテロアリール化合物
WO2016044808A1 (en) 2014-09-19 2016-03-24 New York Blood Center, Inc. Substituted phenylpyrrolecarboxamides with therapeutic activity in hiv
KR102307037B1 (ko) * 2014-09-29 2021-09-30 더 스크립스 리서치 인스티튜트 심폐 장애들의 치료를 위한 스핑고신-1-포스페이트 수용체 조절제들
WO2016054804A1 (en) * 2014-10-10 2016-04-14 Merck Sharp & Dohme Corp. Substituted pyrimidines as inhibitors of hif prolyl hydroxylase
CN111349077B (zh) * 2019-02-02 2022-06-28 杭州华东医药集团新药研究院有限公司 一种哒嗪衍生物及其制备方法和医药用途
GB201908511D0 (en) * 2019-06-13 2019-07-31 Adorx Therapeutics Ltd Hydroxamate compounds
AU2021350973B2 (en) * 2020-09-25 2024-03-07 Shanghai Meiyue Biotech Development Co., Ltd. Pyrimidine carboxamide compound and application thereof
CN116635370A (zh) * 2020-12-21 2023-08-22 英特维特国际股份有限公司 制备n-(双(4-甲氧基苯基)甲基)-6-氧代-2-(哒嗪-3-基)-1,6-二氢嘧啶-5-甲酰胺的方法
CN114835687B (zh) * 2021-04-02 2023-09-05 北京华森英诺生物科技有限公司 AhR抑制剂
BR112023025850A2 (pt) 2021-08-10 2024-03-05 Abbvie Inc Inibidores da nicotinamida ripk1
EP4413000A1 (en) 2021-10-04 2024-08-14 FoRx Therapeutics AG N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancer
GB202301050D0 (en) * 2023-01-25 2023-03-08 Univ Oxford Innovation Ltd PHD Inhibitors
GB202301059D0 (en) * 2023-01-25 2023-03-08 Univ Oxford Innovation Ltd PHD inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853220A1 (de) * 1978-12-09 1980-07-03 Hoechst Ag Neue amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
EP0557879B1 (de) * 1992-02-22 1997-01-08 Hoechst Aktiengesellschaft 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
IL148291A0 (en) * 1999-09-16 2002-09-12 Tanabe Seiyaku Co Aromatic nitrogen-containing 6-membered cyclic compounds
WO2001027105A1 (en) * 1999-10-12 2001-04-19 Takeda Chemical Industries, Ltd. Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
US7273868B2 (en) * 2000-04-28 2007-09-25 Tanabe Seiyaku Co., Ltd. Pyrazine derivatives
HRP20030027A2 (en) * 2000-06-28 2004-02-29 Teva Pharma Carvedilol
JP4179784B2 (ja) * 2001-02-15 2008-11-12 田辺三菱製薬株式会社 口腔内速崩壊性錠
HUP0303841A2 (hu) * 2001-02-20 2004-03-01 Bristol-Myers Squibb Company 2,4-Diszubsztituált-5-pirimidinkarboxamid-származékok mint KCNQ káliumcsatorna modulátorok és ezeket tartalmazó gyógyszerkészítmények és előállításuk
EP1682532B1 (en) * 2003-10-31 2007-06-27 Warner-Lambert Company LLC Pyrimidines as inhibitors of phosphoinositide-3-kinases (pi3k)
US7091202B2 (en) * 2004-09-15 2006-08-15 Bristol-Myers Squibb Company 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
JP2009508838A (ja) * 2005-09-15 2009-03-05 オーキッド リサーチ ラボラトリーズ リミティド 新規のピリミジン・カルボキサミド
US20090143410A1 (en) * 2005-12-14 2009-06-04 Kanu Maganbhai Patel Isoxazolines for Controlling Invertebrate Pests
RU2457204C2 (ru) * 2006-01-27 2012-07-27 Файброджен, Инк. Цианоизохинолиновые соединения (варианты), фармацевтическая композиция на их основе, способ ингибирования активности гидроксилазы гипоксия-индуцибельного фактора (hif) и способ лечения и/или профилактики состояния, связанного с hif, и/или состояния, связанного с эритропоэтином, и/или анемии
JP2009537558A (ja) * 2006-05-16 2009-10-29 スミスクライン・ビーチャム・コーポレイション プロリルヒドロキシラーゼ阻害剤
AR061570A1 (es) * 2006-06-23 2008-09-03 Smithkline Beecham Corp Compuesto de glicina sustituido en el n heteroaromatico composicion farmaceutica que lo comprende, su uso para preparar un medicamento, procedimientos para preparar dicha composicion farmaceutica y para preparar el compuesto
DK3026044T3 (en) * 2006-06-26 2019-02-18 Akebia Therapeutics Inc PROLYL HYDROXYLASE INHIBITORS AND METHODS FOR USE
CA2662091A1 (en) * 2006-09-08 2008-03-13 Novartis Ag N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions

Also Published As

Publication number Publication date
AR070925A1 (es) 2010-05-12
EP2257539A1 (en) 2010-12-08
AU2009225869A1 (en) 2009-09-24
CL2009000639A1 (es) 2009-07-17
US20090239876A1 (en) 2009-09-24
CN102036981B (zh) 2015-04-08
ES2524883T3 (es) 2014-12-15
PE20091627A1 (es) 2009-10-30
JP5557832B2 (ja) 2014-07-23
CA2718528C (en) 2016-10-25
TW200944511A (en) 2009-11-01
AU2009225869B2 (en) 2014-01-23
EP2257539B1 (en) 2014-09-10
CA2718528A1 (en) 2009-09-24
CN102036981A (zh) 2011-04-27
JP2011515402A (ja) 2011-05-19
US8278304B2 (en) 2012-10-02
WO2009117269A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
MX2010010209A (es) 4-hidroxipirimidina-5-carboxamidas sustituidas.
WO2008130600A3 (en) Quinolones and azaquinolones that inhibit prolyl hydroxylase
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
MX2010009765A (es) Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
WO2009111676A3 (en) Boron-containing small molecules as anti-inflammatory agents
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
PT2294066E (pt) Benzoimidazoles como inibidores da prolil-hidroxilase
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
GB2471806A (en) Compositions and methods for treating viral infections
MX354402B (es) Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos.
EP2326178A4 (en) INHIBITORS OF PROLYL-HYDROXYLASE
AU2012289429A8 (en) Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
EA201000915A1 (ru) Ингибиторы пролилгидроксилазы
PL2455381T3 (pl) Triazolopirydynowy związek i jego działanie jako inhibitora hydroksylazy prolinowej i środka indukującego wytwarzanie erytropoetyny
TW200640924A (en) VEGF-R2 inhibitors and methods
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
WO2008137084A3 (en) Diazaquinolones that inhibit prolyl hydroxylase activity
ZA201204104B (en) Prolyl hydroxylase inhibitors
EP2240178A4 (en) PROLYLHYDROXYLASEHEMMER
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
WO2010053573A3 (en) Screen for inhibitors of filovirus and uses therefor
MX2011013878A (es) 4-hidroxipirimidina-5-carboxamidas sustituidas.
EP2326179A4 (en) PROLYLHYDROXYLASEHEMMER
WO2010042636A3 (en) Telomerase inhibitors and methods of use thereof
MX2011006254A (es) Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: MERCK SHARP & DOHME CORP.*

HC Change of company name or juridical status

Owner name: MERCK SHARP & DOHME CORP.*

FA Abandonment or withdrawal